HCA Healthcare, Inc. · NYSE (us_market)
Healthcare · Medical Care Facilities · United States
HCA Healthcare, Inc., through its subsidiaries, provides health care services in the United States. The company owns, manages, and operates hospitals, ASCs, freestanding emergency care facilities, urgent care facilities, walk-in clinics, diagnostic and imaging centers, radiation and oncology therapy centers, as well as rehabilitation and physical therapy centers, physician practices, home health agencies, hospices, outpatient physical therapy providers, home and community-based services providers, and various other facilities. Its general and acute care hospitals offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic services, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy. The company was formerly known as HCA Holdings, Inc. HCA Healthcare, Inc. was founded in 1968 and is headquartered in Nashville, Tennessee.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2024-10-18$415.54 RISE2025-02-28$306.30 PEAK2025-05-16$387.52 210d | -26.3% 133d | Missed | Missed | — | — | +26.5% 77d | Missed |
DROP2024-10-18$415.54 RISE2025-01-03$296.70 PEAK2025-04-02$347.03 166d | -28.6% 77d | Missed | Missed | — | — | +17.0% 89d | Missed |
DROP2023-06-30$303.48 RISE2023-10-26$221.81 PEAK2024-01-22$288.31 206d | -26.9% 118d | Missed | Missed | — | — | +30.0% 88d | Missed |
DROP2022-09-12$222.36 RISE2022-09-30$183.79 PEAK2022-12-14$244.70 93d | -17.3% 18d | Missed | Missed | — | — | +33.1% 75d | Missed |
DROP2022-04-20$275.16 RISE2022-07-06$165.99 PEAK2022-09-12$222.36 145d | -39.7% 77d | Missed | Missed | — | — | +34.0% 68d | Missed |
DROP2020-09-02$138.17 RISE2020-09-23$116.33 PEAK2020-12-17$164.75 106d | -15.8% 21d | Missed | Missed | — | — | +41.6% 85d | Missed |
DROP2020-02-19$150.08 RISE2020-06-26$92.48 PEAK2020-09-02$138.17 196d | -38.4% 128d | Missed | Missed | — | — | +49.4% 68d | Missed |
DROP2020-02-05$151.04 RISE2020-05-15$98.74 PEAK2020-08-10$132.47 187d | -34.6% 100d | Missed | Missed | — | — | +34.2% 87d | Missed |
DROP2020-02-05$151.04 RISE2020-03-18$68.13 PEAK2020-06-08$118.04 124d | -54.9% 42d | Missed | Missed | — | — | +73.3% 82d | Missed |
HCA plans to acquire CHCP, expanding healthcare education efforts and boosting its pipeline of trained professionals across hospitals and care sites.
In recent months, HCA Healthcare has reported weaker-than-expected Q1 2026 adjusted EBITDA amid cost pressures and workforce reductions, even as it continued investing in stroke care quality, community initiatives, and new facilities like the HCA Florida Gainesville Hospital. These developments highlight a tension between HCA Healthcare's operational and community expansion efforts and investor concerns about expenses, regulatory headwinds, and the impact of non-clinical layoffs on future...
In recent months, HCA Healthcare has reported weaker-than-expected Q1 2026 adjusted EBITDA amid cost pressures and workforce reductions, even as it continued investing in stroke care quality, community initiatives, and new facilities like the HCA Florida Gainesville Hospital. These developments highlight a tension between HCA Healthcare's operational and community expansion efforts and investor concerns about expenses, regulatory headwinds, and the impact of non-clinical layoffs on future...
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry’s 1.8% return has trailed the S&P 500 by 9 percentage points.
Personal health and wellness is one of the many secular tailwinds for healthcare companies. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry’s 1.8% return has trailed the S&P 500 by 9 percentage points.
While HCA Healthcare has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.
While HCA Healthcare has lagged behind the broader market over the past year, Wall Street analysts maintain a moderately optimistic outlook on the stock’s prospects.
HCA Healthcare, Inc. (HCA) RBC Capital Markets Global Healthcare Conference 2026 May 20, 2026 11:30 AM EDTCompany ParticipantsChristopher Wyatt - Senior VP,...
MOUNTAIN VIEW, Calif., May 19, 2026 (GLOBE NEWSWIRE) -- Commure, the AI platform for healthcare, today announced $70 million in financing at a $7 billion post-money valuation. The round was led by General Catalyst, with participation from Sequoia Capital, Morgan Stanley, and Kirkland & Ellis. Commure deploys advanced AI and Agents across health systems and practices transforming the day-to-day lives of providers and healthcare administrators. The company is focused on one of the largest cost cen
NASHVILLE, Tenn., May 19, 2026--HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced the results of its seventh annual We Show Up for Our Communities days of service volunteer initiative. In alignment with National Volunteer Month, HCA Healthcare colleagues across the country donated their time and expertise to help improve the health and well-being of the communities the company serves.
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.
HCA Healthcare, Inc. (NYSE:HCA) is one of the Top 10 Stocks That Will Profit from AI. The Tennessee-based company has been integrating generative AI into clinical workflows to automate medical documentation and administrative tasks. Among the most recent developments, HCA Healthcare, Inc. (NYSE:HCA) announced that, through its wholly owned subsidiary, HCA Inc., it completed a […]
HCA Healthcare, Inc. (NYSE:HCA) is one of the Top 10 Stocks That Will Profit from AI. The Tennessee-based company has been integrating generative AI into clinical workflows to automate medical documentation and administrative tasks. Among the most recent developments, HCA Healthcare, Inc. (NYSE:HCA) announced that, through its wholly owned subsidiary, HCA Inc., it completed a […]
April jobs beat forecasts as healthcare, transportation and retail hiring stayed resilient. These sector ETFs and stocks may stay active.
April jobs beat forecasts as healthcare, transportation and retail hiring stayed resilient. These sector ETFs and stocks may stay active.
Let's talk about the popular HCA Healthcare, Inc. ( NYSE:HCA ). The company's shares saw significant share price...
Let's talk about the popular HCA Healthcare, Inc. ( NYSE:HCA ). The company's shares saw significant share price...
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| HCA | -12.60% | -28.97% | -18.92% | -0.75% |
| XLV | +2.97% | -5.72% | -3.44% | +12.69% |
| Alpha (stock − sector) | -15.56% | -23.25% | -15.47% | -13.44% |
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 7.54M | $3.57B | 0.12% | Unchanged | 2026-03-31 |
| FidelityFMR | fundamental | 4.40M | $2.08B | 0.11% | Added+14.8% | 2026-03-31 |
| Wellington | fundamental | 3.91M | $1.85B | 0.35% | Added+14.1% | 2026-03-31 |
| Viking | long/short | 1.08M | $508.80M | 1.42% | Added+7.6% | 2026-03-31 |
| Bridgewater | macro | 173.8K | $82.25M | 0.37% | Trimmed-47.2% | 2026-03-31 |
| DEShaw | quant | 49.9K | $23.63M | 0.01% | Added+10.7% | 2026-03-31 |
| TwoSigma | quant | 1.2K | $578.30K | 0.00% | New | 2026-03-31 |
| TRowePrice | fundamental | 520.3K | $246.24K | 0.03% | Trimmed-7.3% | 2026-03-31 |
| Filed | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-30 | CHIDSEY JOHN | Director | A Grant / award | 809 | — | +$0 |
| 2026-04-30 | DEPARLE NANCY ANN | Director | A Grant / award | 509 | — | +$0 |
| 2026-04-30 | Johnston Hugh F | Director | A Grant / award | 809 | — | +$0 |
| 2026-04-30 | MICHELSON MICHAEL W | Director | A Grant / award | 925 | — | +$0 |
| 2026-04-30 | Riley Wayne Joseph | Director | A Grant / award | 509 | — | +$0 |
| 2026-04-30 | Smith Andrea B | Director | A Grant / award | 509 | — | +$0 |
| 2026-04-30 | FRIST THOMAS F III | Director · 10% Owner | A Grant / award | 1,041 | — | +$0 |
| 2026-04-30 | Frist William R | Director · 10% Owner | A Grant / award | 809 | — | +$0 |
| 2026-02-18 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | M Option exercise(deriv) | 5,000 | — | +$0 |
| 2026-02-18 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | S Open-market sale | 1,694 | $533.37 | −$903.5K |
| 2026-02-18 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | F Tax withholding | 3,306 | $540.29 | −$1.79M |
| 2026-02-18 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | M Option exercise | 5,000 | $236.61 | +$1.18M |
| 2026-02-12 | Cuffe Michael S. | EVP and Chief Clinical Officer | F Tax withholding | 3,501 | $502.05 | −$1.76M |
| 2026-02-12 | Cuffe Michael S. | EVP and Chief Clinical Officer | A Grant / award | 9,628 | — | +$0 |
| 2026-02-12 | Foster Jon M | EVP and COO | F Tax withholding | 5,888 | $502.05 | −$2.96M |
| 2026-02-12 | Foster Jon M | EVP and COO | A Grant / award | 15,696 | — | +$0 |
| 2026-02-12 | HAZEN SAMUEL N | CEO | F Tax withholding | 21,323 | $502.05 | −$10.71M |
| 2026-02-12 | HAZEN SAMUEL N | CEO | A Grant / award | 54,934 | — | +$0 |
| 2026-02-12 | Marks Mike A | EVP and CFO | F Tax withholding | 1,690 | $502.05 | −$848.5K |
| 2026-02-12 | Marks Mike A | EVP and CFO | A Grant / award | 5,026 | — | +$0 |
| 2026-02-12 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | F Tax withholding | 3,006 | $502.05 | −$1.51M |
| 2026-02-12 | McAlevey Michael R | EVP & Chief Legal & Admin Off. | A Grant / award | 8,372 | — | +$0 |
| 2026-02-12 | Rossitto Erica | SVP & Chief Nurse Executive | F Tax withholding | 418 | $502.05 | −$209.9K |
| 2026-02-12 | Rossitto Erica | SVP & Chief Nurse Executive | A Grant / award | 1,676 | — | +$0 |
| 2026-02-12 | Wyatt Christopher F. | SVP & Controller | S Open-market sale | 4,000 | $505.00 | −$2.02M |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-07-24upcoming | 7.38 | — | — |
| 2026-04-24 | 7.13 | 7.15 | +0.29% |
| 2026-01-27 | 7.42 | 8.14 | +9.70% |
| 2025-10-24 | 5.73 | 6.96 | +21.55% |
| 2025-07-25 | 6.32 | 6.84 | +8.21% |
| 2025-04-25 | 5.75 | 6.45 | +12.09% |
| 2025-01-24 | 6.14 | 6.22 | +1.22% |
| 2024-10-25 | 4.98 | 4.90 | -1.64% |
| 2024-07-23 | 4.93 | 5.50 | +11.58% |
| 2024-04-26 | 5.09 | 5.36 | +5.40% |
| 2024-01-30 | 5.05 | 5.90 | +16.79% |
| 2023-10-24 | 3.97 | 3.91 | -1.59% |
| 2023-07-27 | 4.24 | 4.29 | +1.21% |
| 2023-04-21 | 3.92 | 4.93 | +25.81% |
| 2023-01-27 | 4.79 | 4.64 | -3.15% |
| 2022-10-21 | 3.86 | 3.93 | +1.78% |